Scientists Sound Alarm on Underestimated Antidepressant Withdrawal Effects

A new review of antidepressant withdrawal effects– authored by scholars, some of whom have strong connections to pharmaceutical companies – may downplay the possible negative effects onlong-term antidepressant usersby concentrating on brief, industry-supported research.

There is increasing awareness thatstopping antidepressants – particularly following extended use – may lead to serious and occasionally severe effects –ebilitating withdrawal symptoms,and it is now recognized by the UK government as a public health concern.

One of the key factors that led to this matter being acknowledged only after many years since its debut ismodern antidepressantsonto the market is due to medical guidelines, such as those created by Nice (England’sNational Institute for Health and Care Excellence), had for many years described withdrawal symptoms as "short-lived and minor".

This account stemmed from research conducted by pharmaceutical companies, in which participants had only used the medication for eight to 12 weeks. Consequently, when patients later arrived with intense, prolonged symptoms, many healthcare professionals dismissed their concerns since these outcomes conflicted with what the guidelines suggested.

Our latest study sheds light on this discrepancy. We discovered a strong connection between the duration of antidepressant use and the probability of encounteringwithdrawal symptoms– and how intense these symptoms are.

We interviewed NHS patients and discovered that those who had utilizedantidepressantsFor over two years, individuals were ten times more prone to experience withdrawal symptoms, five times more likely to face severe symptoms, and 18 times more likely to encounter prolonged effects compared to those who used the medication for six months or less.

Patients who took antidepressants for a period of less than six months typically experienced mild and short-lived withdrawal effects. Three out of four individuals mentioned having either no symptoms or only minor ones, with most lasting under four weeks.

Just one out of every four patients found it difficult to stop when they wished to. Nevertheless, among those who used the medication for an extended period (over two years), two-thirds experienced moderate or severe withdrawal symptoms, with a quarter facing severe withdrawal effects. Nearly one-third of long-term users mentioned that their symptoms persisted for more than three months. Four-fifths of these individuals struggled to discontinue their antidepressants even after attempting to do so.

Approximately 2 million individuals in England who are on antidepressants have been using them for more than five years, as revealed by a BBC report. In the United States, at least 25 million people have been taking antidepressants for over five years. The outcomes observed in eight-to-12-week studies differ significantly from the experiences of millions when they discontinue the medication.

Examining what occurs in individuals after only eight to 12 weeks of antidepressant use is similar to evaluating car safety by crashing a vehicle into a wall at 5km/h – while overlooking the reality that actual drivers are on the roads traveling at 60km/h.

History repeating itself?

Amidst this context, a review has recently been released inJama Psychiatry. Several senior authors report receiving payments from pharmaceutical companies. It appears to be a case of history repeating itself, as the review relies on short-term studies—many supported by the drug industry—that were comparable to those that influenced initial treatment recommendations. The researchers conclude that antidepressants do not lead to substantial withdrawal symptoms.

Their primary examination relies on eleven studies that comparedsymptoms experienced by individuals who have discontinued antidepressant medication physical and emotional effects following the cessation of antidepressive drugs common reactions when stopping the use of antidepressants physiological and psychological manifestations after discontinuing antidepressant treatment challenges faced by those who have stopped taking antidepressant medications typical signs that occur when ending antidepressant use issues arising from the sudden or gradual withdrawal from antidepressant drugs manifestations of withdrawal in patients who have ceased antidepressant therapyAmong those who kept taking the medication or ceased using a placebo, six studies involved participants on antidepressants for eight weeks, four for 12 weeks, and one for 26 weeks.

They noted a somewhat increased occurrence of withdrawal symptoms among individuals who had discontinued antidepressants, which they claim does not qualify as a "clinically significant" withdrawal syndrome. They also propose that these symptoms might be attributed to the "nocebo effect" – when negative expectations lead individuals to experience worse feelings.

In our opinion, the findings are probably significantly underestimating the risk of withdrawal for the millions of individuals who have been taking these medications for extended periods. The review did not identify a link between the length of antidepressant use and withdrawal symptoms, yet there were insufficient long-term studies to adequately examine this connection.

In our opinion, the review likely overlooks short-term withdrawal effects by assuming that individuals experiencing symptoms when discontinuing a placebo or continuing an antidepressant negates the actual withdrawal effects caused by antidepressants. However, this assumption is not logically sound.

We are aware that the effects of discontinuing antidepressants can resemble both side-effects and typical daily symptoms, but this doesn't imply they are identical. Individuals who stop taking a placebo may experience issues like dizziness and headaches, as these are frequent occurrences. However, as demonstrated in another study,recent review, symptoms that occur after stopping a placebo are usually less severe compared to those that happen when discontinuing antidepressants, which can be strong enough to need immediate medical attention.

Therefore, subtracting the symptom rate following the cessation of a placebo or continuation of an antidepressant from antidepressant withdrawal symptoms may likely result in an underestimation of the actual severity of withdrawal.

The critique also omits several meticulously conducted pharmaceutical industry studies that reported significant instances of withdrawal symptoms. For instance, an Americanstudydiscovered that over 60% of individuals who discontinued antidepressants (following eleven months) encountered withdrawal effects.

The researchers propose that depression following the discontinuation of antidepressants is likely a recurrence of the initial illness, rather than withdrawal effects, as comparable levels of depression were observed in individuals who ceased taking a placebo. However, this finding is supported by limited and questionable data—specifically, information gathered from study participants self-reporting these events without guidance, rather than through structured evaluation—from only five studies.

We hope that uncritical coverage of a review relying on short-term studies, which previously contributed to the underestimation of withdrawal effects, does not hinder the increasing recognition of the issue and delay the health system's efforts to assist millions who could be significantly impacted.

Certain withdrawal symptoms can be serious enough to necessitate immediate medical attention.

Mark Horowitz serves as a guest Clinical Research Fellow in Psychiatry at the University of London, while Joanna Moncrieff holds the position of Professor of Critical and Social Psychiatry at UCL.

This piece was first released by The Conversation and is being shared under a Creative Commons agreement. Read the original.original article

The Independent is the world's most independent-minded news brand, offering international news, opinions, and insights for those who think for themselves. We've built a large, worldwide audience of people who appreciate our reliable voice and dedication to promoting positive transformation. Our goal, to drive change, has never been more crucial than it is now.